Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Udvidet
  • Type 2 biomarkers associated w...
  • Citér dette
  • Stav dette
  • Email dette
  • Udskriv
  • Eksportér post
    • Eksportér til RefWorks
    • Eksportér til EndNoteWeb
    • Eksportér til EndNote
  • Permanent link
Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST

Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST

Bibliografiske detaljer
Main Authors: Wenzel, SE, Pavord, I, Zhang, B, Maroni, J, Rowe, P, Hamilton, JD, Swanson, BN, Amin, N, Pirozzi, G, Graham, NM, Teper, A
Format: Conference item
Udgivet: American Thoracic Society 2018
  • Beholdninger
  • Beskrivelse
  • Lignende værker
  • Medarbejdervisning

Lignende værker

  • Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study
    af: Maspero, J, et al.
    Udgivet: (2018)
  • Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study
    af: Castro, M, et al.
    Udgivet: (2018)
  • Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY ASTHMA QUEST Study
    af: Pavord, I, et al.
    Udgivet: (2018)
  • A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma
    af: Castro, M, et al.
    Udgivet: (2018)
  • Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
    af: Yuji Tohda, et al.
    Udgivet: (2020-10-01)

Søgemuligheder

  • Søg Historie
  • Udvidet søgning

Find flere

  • Gennemse kataloget
  • Gennemse alfabetisk
  • Explore Channels
  • Kursusreservationer
  • Nye værker

Har du brug for hjælp?

  • Søgetips
  • Spørg en bibliotekar
  • FAQ’er